Orbitrex Peptides
Orbitrex Peptides shows its strongest purity-focus evidence in GHK-Cu and later Retatrutide, with identity passes, high purities, and fills generally inside this method's tolerance. Tirzepatide and early Retatrutide are weaker, and the evidence is uneven: Retatrutide has most volume, while GHK-Cu is thinner and batch-source gaps limit traceability.
We investigated who actually operates Orbitrex Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Orbitrex Peptides rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 17 Jul 2026 | Pass | PT-141 Orbitrex Peptides | lab name | View COA | |||
| 17 Jul 2026 | Pass | PT-141 Orbitrex Peptides | lab name | View COA | |||
| 12 Jun 2026 | Pass | Retatrutide Orbitrex Peptides | lab name | View COA | |||
| 2 Jun 2026 | Pass | Retatrutide Orbitrex Peptides | lab name | View COA | |||
| 2 Jun 2026 | Pass | GHK-Cu Orbitrex Peptides | lab name | View COA | |||
| 28 May 2026 | Pass | Retatrutide Orbitrex Peptides | lab name | View COA | |||
| 28 Apr 2026 | Pass | Retatrutide Orbitrex Peptides | lab name | View COA | |||
| 28 Apr 2026 | Pass | Retatrutide Orbitrex Peptides | lab name | View COA | |||
| 23 Apr 2026 | Pass | Retatrutide Orbitrex Peptides | lab name | View COA | |||
| 23 Apr 2026 | Pass | GHK-Cu Orbitrex Peptides | lab name | View COA | |||
About Orbitrex Peptides test results from Finnrick
Orbitrex Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 30 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Orbitrex Peptides peptides in this dataset are Retatrutide (18 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 30 recent tests.